Kibow Biotech, Inc. is pleased to announce that it has been selected to present at the EuroBio 2008 meeting to be held in Paris, October 7-9, 2008. Kibow Biotech, with headquarters in Newtown Square, Pennsylvania, is the only US-based company invited to this prestigious conference among fifteen selected international Bio-Pharma firms.
EuroBio 2008 is considered the Life Sciences Event of the European Union Presidency. Dr. Natarajan Ranganathan, VP (R&D) and interim CEO stated, "Kibow Biotech is very excited about this opportunity to present its Enteric Dialysisâ„¢ technology and its worldwide clinical applications towards chronic kidney failure in patients. It is our intention to seek European based partners to make Kibow products available to a wider audience. Through collaboration, Kibow Biotech will establish a world-wide presence."
For more information, visit http://www.kibow.com
About Kibow Biotech Kibow Biotech Inc. is an eleven-year-old, developing-stage biotechnology company having its operations in Newtown Square, PA, USA. The company's mission is dedicated to finding a simple, convenient and cost-effective worldwide solution for patients suffering kidney failure. The company's first generation product called Kibow Biotics(R), an orally consumable, enteric coated Gel Cap product formulation is composed of food grade microbes ("Probiotics") which metabolize the uremic toxins diffusing into the bowel as a consequence of increased levels of these toxins in the blood. It is targeted to help augment or maintain kidney function both for Chronic Kidney Disease (CKD) patients (pre-dialysis) and End Stage Renal Disease (ESRD) patients.
For additional information, contact: Dr. Natarajan Ranganathan CEO and VP Research and Development Kibow Biotech, Inc. 4629 West Chester Pike Newtown Square, PA 19073 USA Tel: (610) 353 5130 Fax: (610) 353 5110 Email address: rangan@kibowbiotech.com Web site: http://www.kibow.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment